Tepezza Restock Coming; Osteoporotic Fractures Broken Down by State

(MedPage Today) -- The FDA gave the green light to Horizon Therapeutics to resume production on its thyroid eye disease treatment teprotumumab-trbw (Tepezza) after priority was given to manufacturing the COVID-19 vaccine.
An updated guideline...